ALNY vs NATH · P/E 76, rev $1.29B vs P/E 21, rev $162.1M
Alnylam Pharmaceuticals Inc (ALNY) versus Nathans Famous Inc (NATH) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Nathans Famous Inc (NATH) is a restaurants company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported NATH revenue for 2026-03-29 was $162.1M. Net income was $20.0M. Revenue was up 9.4% from 2025-03-30 to 2026-03-29. NATH currently screens at market cap $415.9M and trailing P/E 20.9.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. NATH currently screens at market cap $415.9M and trailing P/E 20.9.
Not investment advice. Open the ALNY and NATH stock pages for the full models.
Not investment advice.